ArticleBMJ public health2026
What factors were associated with human papillomavirus vaccine hesitancy among parents of adolescent girls? A mixed-methods study in Southwestern Nigeria.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vaccine hesitancy contributes to the dampened public enthusiasm for vaccination in several countries, including Nigeria. Human papillomavirus (HPV) vaccine acceptance is influenced by various factors; studies have examined some of these factors in sub-Saharan Africa, including Nigeria. This study aimed to examine HPV vaccine hesitancy and associated factors among parents of adolescent girls in Ibadan North East Local Government Area based on the WHO 3C model. Methods: A cross-sectional mixed-methods study was conducted, comprising four Focus Group Discussion sessions with parents and semistructured, interviewer-administered questionnaires, using a multistage sampling procedure to select 402 parents. Quantitative data were analysed using descriptive statistics, χ Results: The mean age of parents was 43.7±7.4 years, 66.9% were women, 50.7% identified as Christians and 95.0% belonged to the Yoruba ethnic group. Respondents were knowledgeable about HPV infection (51.5%) and HPV vaccine (64.7%); 61.4% had a positive attitude towards HPV vaccination. About 27.4% were hesitant to receive the HPV vaccine. The perceived necessity of vaccine (adjusted OR (AOR)=4.61, CI 1.14 to 18.72), trust in the efficacy of vaccines (OR=3.54, CI 1.09 to 11.51) and HPV vaccine safety (AOR=8.46, CI 2.73 to 26.18) had a higher influence on HPV vaccine hesitancy, while availability of the vaccine (AOR=0.23, CI 0.11 to 0.50) had a lesser influence. Conclusions: There was a significant level of HPV vaccine hesitancy among parents of adolescent girls, and associating factors included limited knowledge about HPV and its vaccine, as well as concerns about vaccine safety, vaccine necessity and vaccine availability. There is a need for targeted public health interventions that contribute to the prevention of HPV-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.